Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John Saganty
Institutions:
University Hospitals of North Midlands NHS Trust,
Royal Stoke University Hospital
Observed institutions:
University of Aberdeen,
University of Cambridge,
University Hospitals of North Midlands NHS Trust,
Royal Stoke University Hospital,
MRC Cancer Unit,
Medical Research Council
show all 6
ORCID:
0000-0002-3523-227X
Observed ORCID:
0000-0002-3523-227X
OpenAlex ID:
A5012809020
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
2023
·
Subarnarekha Chatterji
, Emma Krzoska
, et al.
·
The Lancet Oncology
·
35
Multiplexed biochemical imaging reveals caspase activation patterns underlying single cell fate
2018
·
Maximilian W. Fries
, Kalina T. Haas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
PDF
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations
2024
·
Laura Smith
, John Saganty
, et al.
·
Current Oncology Reports
·
3
PDF
Conservative Management of Non‐Tension Pneumothorax Following Drainage of Pleural Empyema
2025
·
John Saganty
, Will D. Carroll
, et al.
·
Pediatric Pulmonology
Show more works
View as search
Works count:
4
Citation count:
43
H-index:
3
I10-index:
1
Year
Topic
Type